Forlax powder for solution for children package 4g N20
Condition: New product
1000 Items
Rating:
Be the first to write a review!
More info
Active ingredients
Macrogol
Release form
Powder
Composition
The composition of one package: Active ingredient: Macrogol 4000 (Polyethylene glycol 4000) 4000.0; Auxiliary components: Fragrance with the smell of orange and grapefruit * 60.0; Sodium saccharinate 6.8; * Orange oil, grapefruit oil, orange juice concentrated ,; citral, acetaldehyde, linalol, ethyl butyrate, alpha terpineol; octanal, cis-3-hexenol, maltodextrin, acacia gum, sorbitol.
Pharmacological effect
The large molecular weight of macrogol 4000 is due to long linear polymers that retain water molecules through hydrogen bonds. Due to this, the volume of intestinal contents increases after oral administration of the drug. The volume of unabsorbed fluid in the intestinal lumen supports the laxative effect of the solution.
Pharmacokinetics
Pharmacokinetic data confirm that macrogol 4000 is not exposed to either gastrointestinal resorption or biotransformation when taken orally.
Indications
Symptomatic treatment of constipation in children aged 6 months to 8 years.
Contraindications
- severe inflammatory bowel disease (ulcerative colitis, Crohn's disease) or toxic megacolon; - perforation or risk of perforation of the intestine; - complete or partial intestinal obstruction, as well as suspicion of intestinal obstruction, symptomatic stenosis; - abdominal pain of unknown etiology; - hypersensitivity to macrogol (polyethylene glycol) or to other components of the drug .;
Use during pregnancy and lactation
Not applicable.
Dosage and administration
Inside.; - from 6 months to 1 year: 1 sachet per day;; - from 1 year to 4 years: from 1 to 2 sachets per day; - from 4 to 8 years: from 2 to 4 sachets per day. ; The contents of one sachet should be dissolved in approximately 50 ml of water and taken in the morning (if the dosage is 1 sachet per day), or taken in the morning and in the evening (if the dosage is more than 1 sachet per day) .; Duration of treatment is not more than 3 months .; The action of Forlax appears 24 to 48 hours after administration. Maintaining the effect after the restoration of normal bowel function should be carried out with the help of an active lifestyle and a diet rich in plant fiber.; If the symptoms of constipation persist for more than 3 months, it is necessary to conduct a re-extended diagnostic examination.
Side effects
Data on adverse reactions are presented according to the following classification: very often (≥1 / 10), often (≥1 / 100 - <1/10), infrequently (≥1 / 1,000 to <1/100), rarely (<1 / 1,000), very rarely (≥1 / 10,000). Mostly undesirable reactions are mild transient and most often associated with gastrointestinal disorders. Often: abdominal pain, diarrhea *.; * Diarrhea can cause irritation of the perianal area; Not often: nausea, vomiting, bloating. practice (with a frequency that cannot be estimated on the basis of available data): extremely rare cases of hypersensitivity ** in the form of rash, urticaria, and angioedema; ** Information is provided on the basis of data collected for all preparations containing Macrogol in the GOVERNMENTAL dosages. If any of the side effects indicated in the instruction are aggravated, or you have noticed any other side effects not indicated in the instruction, inform your doctor.
Overdose
An overdose of the drug leads to diarrhea, followed by disappearance after dose reduction or cessation of treatment. Intense diarrhea or vomiting can cause an imbalance of the electrolyte balance, which will require its correction. There are reports of the appearance of inflammation and irritation of the perianal area and fecal incontinence in cases of using polyethylene glycol in large volumes (4–11 liters) to clean the intestines before colonoscopy. ;
Interaction with other drugs
Slows the absorption of concurrently taken drugs. Therefore, it is recommended to prescribe Forlax after at least 2 hours after other drugs are prescribed .;
special instructions
Very rare cases of hypersensitivity have been reported (including rashes, urticaria, edema) while taking medications containing macrogol (polyethylene glycol). In exceptional cases, anaphylactic shock was observed. Due to the presence of sorbitol, patients with congenital intolerance; fructose should not take this drug. Aspiration cases have been reported when large amounts of macrogol and electrolytes were injected with a nasogastric probe. Children with neurological disorders who have a violation of swallowing are at risk of aspiration.